Xianwen Hu, Haojun Duan, Ying Zhao, Yongpeng Wang, Dongfeng Pan
{"title":"病例报告:18F-FDG PET/CT显示鼻窦横纹肌肉瘤治疗改善后弥漫性胰腺转移。","authors":"Xianwen Hu, Haojun Duan, Ying Zhao, Yongpeng Wang, Dongfeng Pan","doi":"10.3389/fmed.2025.1609837","DOIUrl":null,"url":null,"abstract":"<p><p>Metastasis of rhabdomyosarcoma (RMS) from primary paranasal sinuses to the pancreas is rare. Herein, we present a rare case of diffuse pancreatic metastasis in a 44-year-old man. He was diagnosed with sinus RMS 1 year ago and the lesion disappeared after systematic treatment. The patient came to our hospital in November 2022 due to abdominal pain. Abdominal ultrasound showed diffuse enlargement of the pancreas, with enlarged lymph nodes visible around the pancreas and retroperitoneum. He then underwent positron emission tomography/computed tomography (PET/CT) imaging and the results showed that the pancreas had diffusely increased fluorine-18 fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake, and the surrounding pancreas and retroperitoneal lymph nodes also had increased <sup>18</sup>F-FDG uptake, suggesting a possibility of malignant tumor. Ultimately, a pancreatic puncture biopsy confirmed RMS with pancreatic and abdominal lymph nodes metastasis. Our case suggests that although diffuse metastatic tumors of the pancreas are relatively rare, which should be considered as one of the differential diagnoses for diffuse pancreatic hypermetabolic lesions on PET/CT imaging.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1609837"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162518/pdf/","citationCount":"0","resultStr":"{\"title\":\"Case Report: <sup>18</sup>F-FDG PET/CT revealed diffuse pancreatic metastasis in paranasal sinuses rhabdomyosarcoma after treatment improvement.\",\"authors\":\"Xianwen Hu, Haojun Duan, Ying Zhao, Yongpeng Wang, Dongfeng Pan\",\"doi\":\"10.3389/fmed.2025.1609837\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Metastasis of rhabdomyosarcoma (RMS) from primary paranasal sinuses to the pancreas is rare. Herein, we present a rare case of diffuse pancreatic metastasis in a 44-year-old man. He was diagnosed with sinus RMS 1 year ago and the lesion disappeared after systematic treatment. The patient came to our hospital in November 2022 due to abdominal pain. Abdominal ultrasound showed diffuse enlargement of the pancreas, with enlarged lymph nodes visible around the pancreas and retroperitoneum. He then underwent positron emission tomography/computed tomography (PET/CT) imaging and the results showed that the pancreas had diffusely increased fluorine-18 fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake, and the surrounding pancreas and retroperitoneal lymph nodes also had increased <sup>18</sup>F-FDG uptake, suggesting a possibility of malignant tumor. Ultimately, a pancreatic puncture biopsy confirmed RMS with pancreatic and abdominal lymph nodes metastasis. Our case suggests that although diffuse metastatic tumors of the pancreas are relatively rare, which should be considered as one of the differential diagnoses for diffuse pancreatic hypermetabolic lesions on PET/CT imaging.</p>\",\"PeriodicalId\":12488,\"journal\":{\"name\":\"Frontiers in Medicine\",\"volume\":\"12 \",\"pages\":\"1609837\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162518/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fmed.2025.1609837\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1609837","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Case Report: 18F-FDG PET/CT revealed diffuse pancreatic metastasis in paranasal sinuses rhabdomyosarcoma after treatment improvement.
Metastasis of rhabdomyosarcoma (RMS) from primary paranasal sinuses to the pancreas is rare. Herein, we present a rare case of diffuse pancreatic metastasis in a 44-year-old man. He was diagnosed with sinus RMS 1 year ago and the lesion disappeared after systematic treatment. The patient came to our hospital in November 2022 due to abdominal pain. Abdominal ultrasound showed diffuse enlargement of the pancreas, with enlarged lymph nodes visible around the pancreas and retroperitoneum. He then underwent positron emission tomography/computed tomography (PET/CT) imaging and the results showed that the pancreas had diffusely increased fluorine-18 fluorodeoxyglucose (18F-FDG) uptake, and the surrounding pancreas and retroperitoneal lymph nodes also had increased 18F-FDG uptake, suggesting a possibility of malignant tumor. Ultimately, a pancreatic puncture biopsy confirmed RMS with pancreatic and abdominal lymph nodes metastasis. Our case suggests that although diffuse metastatic tumors of the pancreas are relatively rare, which should be considered as one of the differential diagnoses for diffuse pancreatic hypermetabolic lesions on PET/CT imaging.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world